RxDoctor Payments Data

Marjorie Beigle

Adult Health · Harbor Springs, MINPI 1164206637

Payments from drug & device makers

$2,171in general payments, 2019–2025

Across 40 payments — averaging $54.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$814
  • Calyxo, Inc.$615
  • Olympus America Inc.$295
  • Johnson & Johnson$255
  • Endo USA, Inc.$45
  • Astellas Pharma US Inc$40
  • plus $106 from 4 others

What the payments were for

  • Travel & lodging$1547%
  • Food & beverage$2,01693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,171 in reported general payments places this provider in the 80th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$26,525
Medicare patients
246
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron68$41,570
Mirabegron ErMirabegron23$11,890
Tamsulosin Hcl208$3,319
Methenamine Hippurate36$3,025
Oxybutynin Chloride ErOxybutynin Chloride196$2,915
Estradiol37$2,392
Potassium Citrate ErPotassium Citrate28$738
Finasteride28$572
Testosterone11$528
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst39$517
Cephalexin140$347
Ciprofloxacin Hcl47$155
Oxybutynin Chloride18$152
Solifenacin Succinate12$112
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$40$41,57068 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 527 adult health providers in Michigan.

Other adult health in Harbor Springs

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →